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The efficacy of topical testosterone treatment on preputial
microvessel density in distal hypospadias
Mustafa Çağrı SAVAŞ1, Şirin BAŞPINAR2, Levent DUMAN1, Fatma Nilgün KAPUCUOĞLU2

Aim: To investigate the efficacy of topical testosterone treatment on the microvessel density (MVD) of hypospadiac
prepuce.
Materials and methods: The prepuces of 20 healthy children undergoing routine circumcision served as the control
group, while the prepuces of 20 children undergoing hypospadias repair served as the hypospadias group. The
hypospadias group was further divided into 2 equal subgroups (n = 10) as the hypospadias with or without testosterone
treatment groups. The meatal locations were coronal and subcoronal in all of the patients with hypospadias. The prepuces
were stained by immunohistochemical methods using panendothelial cell antigen CD31 in order to assay their MVD.
The statistical analysis among the groups was done using one-way analysis of variance.
Results: The MVD was significantly lower in the hypospadias without treatment group than in the control group (37.16
± 18.20 vs. 58.75 ± 24.98; P = 0.037). Preoperative testosterone treatment increased the mean MVD to 51.92 ± 10.21 in
the treatment group, but it was not statistically significant (P = 0.116).
Conclusion: Topical testosterone treatment prior to hypospadias surgery restores defective MVD in the prepuce, but
this desired effect is unsatisfactory with a single application of a high dose of testosterone.
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Introduction
Preputial vascularity is crucial for hypospadias repair,
because the prepuce is used for the reconstruction
of the neourethra and penile skin coverage (1).
The vascular anatomy of the prepuce is also
important when choosing the operative technique
in hypospadias, and a better knowledge of preputial
vascular anatomy may improve the surgical outcome
(2). The morphological characteristics and the
vascular anatomy of the hypospadiac prepuce, and
the correlation among them, have been previously
documented (1,3). The defective vessel pattern
of the hypospadiac prepuce has also been shown
(2). Microvessel density (MVD) has been used

for vascular analysis in tissue samples for several
decades. In this respect, we compared the vascularity
of normal and hypospadiac prepuces using MVD in
our previous study, and we demonstrated the defect in
the MVD of the hypospadiac prepuce and its negative
correlation with the severity of hypospadias (4).
Topical or intramuscular preoperative testosterone
treatment has been used to increase the penile length
in hypospadiac children with micropenis in order
to permit easier surgical repair and to decrease
the postoperative complications (5,6). Increased
preputial vascularity is important for the final
outcome in hypospadias surgery. Testosterone
stimulates angiogenesis and vascular regrowth (7).
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Thus, a prospective clinical trial was designed in
order to clarify the impact of preoperative topical
testosterone treatment on preputial MVD.
Materials and methods
Permission from the institutional review board was
obtained before this clinical trial (IRB approval:
2177-TU-10). Informed consent was obtained from
one of the parents of each patient before the study.
Study groups
The prepuces of 20 children, aged between 2 and 12
years (mean: 5.65 ± 3.03 years) with distal hypospadias
undergoing surgical repair, were included in the study.
The prepuces of 20 healthy age-matched (mean: 5.10 ±
3.30 years) children undergoing routine circumcision
served as the control group. The hypospadias group
was further divided into 2 equal subgroups (n = 10)
as the hypospadias with or without treatment groups.
No randomization was performed between the
hypospadias subgroups. The patients who required
penile lengthening were included in the treatment
group, and an ampoule of testosterone (Sustanon,
1 mL, 250 mg; Schering Plough) was applied
topically to the penis and prepuce of the patients 1
month before the operation. The meatal locations
were coronal and subcoronal in all of the patients
with hypospadias. Cases with glanular hypospadias
and redo operations were excluded from the study.
None of the control subjects had suffered an attack
of balanitis before circumcision. The same surgeon
operated on all of the patients. The most distal part of
the inner preputial layer from the dorsal side of the
penis was harvested for histological evaluation.
Immunohistochemistry
Immunohistochemical staining was carried out
with the avidin–biotin–peroxidase system using
a monoclonal antibody (CD31/PECAM-1, clone
JC/70A; Lab Vision Corp., Fremont, CA, USA)
against the panendothelial cell antigen CD31 (platelet/
endothelial cell adhesion molecule). Briefly, 4-µmthick consecutive sections were deparaffinized and
hydrated through a graded series of alcohol. After
the inhibition of endogenous peroxidase activity
by immersion in 3% H2O2/methanol solution, the
antigen retrieval was conducted using 10 mmol/L of
citrate buffer (pH 6.0) in a microwave oven for 10 min

at 120 °C. The sections were incubated with primary
antibodies, thoroughly washed in phosphate-buffered
saline, and then incubated with biotinylated secondary
antibody followed by the avidin–horseradish
peroxidase complex (Lab Vision). Finally, the immune
complexes were visualized by incubation with DAB
chromogen (Lab Vision), and nuclear counterstaining
was accomplished with Mayer’s hematoxylin. As a
negative control, appropriately diluted nonimmune
sera were applied instead of the primary antibody.
All of the negative controls showed low background
staining (data not shown).
Determination of microvessel density
The preputial microvessels included capillaries
and small venules and arterioles. When measuring
the MVD, single endothelial cells were excluded
because they cannot be considered as microvessels.
The presence of a vascular lumen was not necessary
to identify a microvessel. Care was taken to select
microvessels, i.e. capillaries and small venules, from
all of the CD31-stained vessels. They were identified
as transversally sectioned tubes with a single layer
of endothelial cells, either with or without a thin
basement membrane. Using a light microscope
(Olympus CX 41, Hamburg, Germany), areas of
high-density staining were identified in low-power
(100×) fields by 2 pathologists who were blinded
to the patient groups. Most of the CD31-positive
microvessels were identified in this area, which thus
resembled an “extended hot spot” of angiogenesis.
Neovascularity was counted in 5 random high-power
(200×) fields within these hot spots. The mean results
were recorded for analysis.
Statistical analysis
All of the data are reported as means ± 1 standard
deviation. Data were analyzed using SPSS 17.0 for
Windows (SPSS Inc., Chicago, IL, USA). The Shapiro–
Wilk test confirmed that the data were distributed
normally (P = 0.211; >0.05 confirms normal
distribution), and Levene’s statistic test of homogeneity
confirmed that the data were nonhomogeneous (P =
0.001; >0.05 confirms homogeneity of variances).
Thus, statistical analysis among the groups was done
by one-way analysis of variance followed by Dunnett’s
T3 test as a post hoc for the pairwise comparisons. All
of the tests were 2-sided and P < 0.05 was considered
statistically significant.
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Results
The MVDs of the groups are shown in Figure 1. The
MVD was significantly lower in the hypospadias
without treatment group than in the control group
(37.16 ± 18.20 vs. 58.75 ± 24.98; P = 0.037). Although
it was not statistically significant (P = 0.116),
preoperative treatment with topical testosterone
increased the preputial MVD in the treatment
group when compared to the hypospadias without
treatment group (51.92 ± 10.21 vs. 37.16 ± 18.20)
(Figure 2).
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Figure 1. The MVDs of the groups. The MVD was significantly
lower in the hypospadias without treatment group
than in the control group (P = 0.037). Although it was
not statistically significant (P = 0.116), preoperative
treatment with topical testosterone increased preputial
MVD in the treatment group.

Discussion
The prepuce is used for reconstruction of the
neourethra and penile body skin in hypospadias
surgery. Therefore, a well-vascularized prepuce

A

B

is extremely important for the outcome of the
surgery. Perovic and Radojicic (1) investigated the
development, course, and distribution of the preputial
blood vessels in hypospadiac patients, and they applied
the results of the study to the surgical correction of
the pathology. They showed that the prepuces were
well vascularized, with a predominant 1 or 2 blood
vessels in 70% of the patients. However, a net-like
vascularization with no predominant blood vessels
was found in 30% of the patients. They concluded that
a prepuce with a net-like vascularization without 1 or
2 predominant arteries was unsuitable for preparing
well-vascularized preputial flaps for reconstruction of
the neourethra. However, the surgical outcome of the
patients (complication rates) and its correlation with
the vascular pattern of the prepuce were surprisingly
absent in the results of their study.
In another study, morphological classification,
along with the vascular pattern of hypospadiac
prepuces and the impact of the surgical outcome,
was done. This showed a significant correlation
between the morphology and vascularization of the
prepuces. Underdeveloped prepuces and those with
an unfavorable vascular pattern used for urethroplasty
had a higher percentage of complications (3). Yucel
et al. (2) compared the blood vessel patterns of
hypospadiac and normal patients. They showed
that a net-like arterial system was more common in
hypospadiac patients (47%). They concluded that
the identification of the vascular anatomy of the
hypospadiac prepuce prior to reconstruction of the
neourethra with preputial flaps may improve the
surgical outcome, especially in proximal cases. Soyer

C

Figure 2. The microscopic appearance of the microvessels (200×): A) Normal immunohistochemical CD31 staining of microvessels
in the control group, as marked by arrows; B) arrow indicates the decreased preputial microvessels in a hypospadiac patient
without testosterone treatment; and C) testosterone treatment increased the preputial microvessels.
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et al. (8) revealed that not only the vascular anatomy
but also angiogenesis may be defective in hypospadiac
prepuces. The results of these studies were very
suggestive in order to investigate the defective preputial
MVD in children with hypospadias. Thus, the MVD of
the hypospadiac prepuce was investigated to evaluate
neovascularization by means of immunohistochemical
methods, using a monoclonal antibody against the
panendothelial cell antigen CD31, in our previous
study. Our results demonstrated that the MVD of the
hypospadiac prepuces was significantly lower than
that of the healthy controls, and a gradual decrease
in the MVD was also observed in proportion to the
severity of the hypospadias (4).
Testosterone treatment prior to hypospadias
surgery in order to increase penile length has been
shown to be beneficial (5,6). In an experimental
transplant model, the treatment of human foreskin
with testosterone increased vascularity and
decreased early fibrosis (9). In another experimental
study, postoperative administration of testosterone
in rabbits following hypospadias repair changed the
histologic composition of the urethral epithelium
and led to an exaggerated inflammatory response
in the supportive stroma (10). More recently, the
application of 1% testosterone propionate ointment
before hypospadias surgery was shown to induce

neovascularization, increasing the absolute number
of vessels and blood volume density (11). In this
study, topical testosterone was applied twice daily for
30 days. Nevertheless, we applied a single high topical
dose of testosterone 1 month before the operation.
We also used an injectable form of testosterone for
topical treatment. The absorption of this form may
be insufficient for hormonal stimulation. This short
and insufficient stimulation is probably responsible
for the statistically insignificant difference in MVDs
between the hypospadias subgroups in our study.
Preoperative topical testosterone treatment
increased the neovascularization of the prepuce
in patients with hypospadias, but this desired
effect is unsatisfactory with a single application of
testosterone. The number of patients and the degree
of hypospadias (only distal cases) were the limitations
of the present study. Larger series with more severe
cases and repeated doses are needed in order to
clarify the effects of preoperative topical testosterone
treatment on preputial MVD.
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